The Hubrecht Institute is a research institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), situated on the campus of the largest university in the Netherlands (Utrecht). Research focuses on developmental and stem cell biology of animals in the widest sense.
The Hubrecht Institute is led by a board of directors, consisting of Prof. Alexander van Oudenaarden (director), Prof. Jeroen den Hertog ( deputy director research.) and Dr. Mariëtte Oosterwegel (managing director). Presently there are 20 research groups with a total of about 225 employees. The research groups operate in an independent manner and scientific quality is guaranteed by regular evaluations by site visit committees (every 5-7 years). In addition to a highly interactive and international scientific environment, excellent research facilities are available on-site for imaging and functional genomics. Moreover, several model organisms are maintained within the institute, including C. elegans, Drosophila, zebrafish, mice and rats.
The Hubrecht Institute is financed by the KNAW, which is itself subsidized by the Ministry of Education, Culture and Science. Since 2008 the institute is affiliated with the University Medical Center Utrecht (UMC Utrecht). This affiliation allows the institute to develop further into an international renowned institute in the field of biomedical research by adding 70% to the basic financing that the institute receives from the KNAW. Financing of the research projects largely depends on project grant organizations both nationally and internationally, including the Netherlands Organisation for Scientific Research (NWO), the Dutch Cancer Society (KWF), the European Research Council (ERC) and the European Commission (EC).
The research groups participate in numerous national and international co-operations like the Cancer Genomics Center and the Center for Biomedical Genetics.
The scientific advisory board of the Hubrecht Institute consists of the following outstanding members of the international research community:
Prof. Dr. René Medema - Netherlands Cancer Institute, Amsterdam (chairman)
Prof. Dr. Peter Verrijzer – ErasmucMC, Rotterdam
Prof. Dr. Denis Duboule - University of Geneva, Geneva
Prof. Dr. Han Brunner - Radboud University Nijmegen Medical Center, Nijmegen
Prof. Dr. Daniel Louvard - Institut Curie, Paris
Prof. Dr. Sander Tans - AMOLF institute, Amsterdam